Semprus BioSciences

Semprus BioSciences is a biomedical company based in Cambridge, Massachusetts, focused on advancing medical device technology. The company has developed an innovative antimicrobial coating technology designed for vascular access catheters, which aims to reduce both microbial adherence and thrombus accumulation throughout the device's lifecycle. This breakthrough in surface modification represents a significant advancement in the medical device market, allowing for the coating of devices of various sizes, shapes, and materials. Semprus has successfully raised a total of $28.5 million in equity financing, with notable investments from firms such as SR One and Foundation Medical Partners.